The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies
about
Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report.Nodding syndrome, infections and sexuality.Antibiotic resistance status and its costs in hematological patients: A two-year analysis.
P2860
The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The outcome of non-carbapenem- ...... ith hematological malignancies
@en
The outcome of non-carbapenem- ...... th hematological malignancies.
@nl
type
label
The outcome of non-carbapenem- ...... ith hematological malignancies
@en
The outcome of non-carbapenem- ...... th hematological malignancies.
@nl
prefLabel
The outcome of non-carbapenem- ...... ith hematological malignancies
@en
The outcome of non-carbapenem- ...... th hematological malignancies.
@nl
P2093
P2860
P356
P1476
The outcome of non-carbapenem- ...... ith hematological malignancies
@en
P2093
T Yildirmak
P2860
P304
P356
10.4314/AHS.V13I2.24
P577
2013-06-01T00:00:00Z